Xiaohui Zha profile picture

Contact Information

Xiaohui Zha, Ph.D.
613-737-8899 x73268
Xzha@ohri.ca

Fax: 613-737-8803

ORCID logo https://orcid.org/0000-0003-2873-3073

Xiaohui Zha

Senior Scientist, Inflammation & Chronic Disease
Ottawa Hospital Research Institute
Professor, Department of Medicine & Department of Biochemistry, Microbiology and Immunology
University of Ottawa

Research Interests

• Cholesterol regulation and transport in mammalian cells
• Plasma membrane: nanodomains and phospholipid asymmetry between leaflets
• Cholesterol regulation of metabolic processes
• Cholesterol regulation of histone modifications and epigenome
• Cholesterol regulation of Macrophage inflammation

Brief Biography

Dr. Zha earned her Ph.D. in Chemistry from Cornell University, where she specialized in secondary ion mass spectrometry (SIMS). She completed her postdoctoral training in cell biology at Columbia University with Dr. Fred Maxfield, applying advanced fluorescence microscopy to investigate cellular membrane dynamics. During this time, she developed a lasting interest in cholesterol biology—specifically, how cholesterol dysregulation contributes to human disease.

Her research program seeks to uncover the fundamental roles of cholesterol: what it does, why it is unique to animals, and how its imbalance underlies a range of modern health disorders. Emerging findings suggest that cholesterol functions as an environmental factor that shapes immune responses, highlighting the importance of maintaining low plasma cholesterol to protect against acute infections.

More recently, Dr. Zha has focused on macrophages, examining how cholesterol influences their inflammatory responses through epigenetic reprogramming. Using genomic tools such as ChIP-seq, RNA-seq, and ATAC-seq, her team is identifying cholesterol-regulated epigenetic pathways that drive macrophage plasticity and immune polarization.

Selected Publications

1. Salloum Z, Dauner K, Li YF, Verma N, Valdivieso-González D, Almendro-Vedia VG, Zhang JD, Nakka K, Chen MX, McDonald JG, Corley CD, Sorisky A, Song BL, López-Montero I, Luo J, Dilworth JF, Zha X. “Statin-mediated reduction in mitochondrial cholesterol primes an anti-inflammatory response in macrophages by upregulating Jmjd3.” Elife. 2024 Apr 11;13:e85964. 

2. Nakka K, Hachmer S, Mokhtari Z, Kovac R, Bandukwala H, Bernard C, Li Y, Xie G, Liu C, Fallahi M, Megeney LA, Gondin J, Chazaud B, Brand M, Zha X, Ge K, Dilworth FJ. “JMJD3 activated hyaluronan synthesis drives muscle regeneration in an inflammatory environment”. Science. 2022 Aug 5;377(6606):666-669.

3. Singh RK, Haka AS, Bhardwaj P, Zha X and Maxfield FR, “Dynamic Actin Reorganization and Vav/Cdc42-dependent Actin Polymerization Promote Macrophage Aggregated LDL Uptake and Catabolism” Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB), 2019, Feb; 39(2): 137-149.

4. Courtney KC, Fung KYY, Maxfield FR, Fairn GD, Zha X, “Comment on “Orthogonal lipid sensors identify transbilayer asymmetry of plasma membrane cholesterol.” ELife, 2018, Nov. 13; 7-10.

5. Courtney KC, Pezeshkian W, Raghupathy R, Zhang C, Darbyson A, Ipsen JH, Ford DA, Khandelia H, Presley JF, Zha X, “C24 Sphingolipids Govern the Transbilayer Asymmetry of Cholesterol and Lateral Organization of Model and Live-Cell Plasma Membranes.” Cell Reports, 2018 Jul 24;24(4):1037-1049.

6. Eid W, Dauner K, Courtney, Gagnon A, Parks R, Sorisky A, Zha X, “mTORC1 Activates SREBP-2 by Suppressing Cholesterol Trafficking to Lysosomes in Mammalian Cells”, Proc. Natl. Acad. Sci. 2017, Jul 25;114(30):7999-8004.

7. Dauner K, Eid W, Raghupathy R, Presley JF, Zha X, “mTOR complex 1 activity is required to maintain the canonical endocytic recycling pathway against lysosomal delivery”. J. Biol. Chem., 2017, April 7;292(14):5737-5747.
 

Diseases, conditions and populations of interest





Research and clinical approaches